Decoy Therapeutics (DCOY) vs Revelation Biosciences (REVB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Revelation Biosciences is the larger company by market cap ($2.0 million vs $2.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DCOY | REVB |
|---|---|---|
| Share price | $0.8294 | $3.50 |
| Market cap | $1.98M | $1.99M |
| 1-day change | -4.68% | -5.15% |
| P/E ratio (TTM) | 0.03 | — |
| EPS (TTM) | $31.19 | $-99.96 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-12.52M | $-8.91M |
| 52-week high | $16.92 | $40.60 |
| 52-week low | $0.80 | $3.08 |
| Distance from 52-week high | -95.10% | -91.38% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +261.71% | +407.14% |
| Average volume | 2.17M | 12.49K |
| Shares outstanding | 2.39M | 569.06K |
| Employees | 11 | 8 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Decoy Therapeutics
DCOY stock →Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company.
Health Care · Biotechnology: Pharmaceutical Preparations · 11 employees
About Revelation Biosciences
REVB stock →Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health.
Health Care · Biotechnology: Pharmaceutical Preparations · 8 employees
DCOY vs REVB FAQ
Which is bigger, Decoy Therapeutics or Revelation Biosciences?
Revelation Biosciences (REVB) is larger, with a market capitalization of $1.99M compared with $1.98M for Decoy Therapeutics (DCOY).
Are Decoy Therapeutics and Revelation Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.